Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.76 USD | -0.80% | -2.50% | -14.61% |
May. 16 | Everlasting momentum | |
May. 16 | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.59% | 89.42B | |
+31.99% | 694B | |
+29.12% | 593B | |
-1.62% | 371B | |
+19.71% | 331B | |
+6.57% | 290B | |
+14.13% | 239B | |
-3.11% | 209B | |
+9.91% | 209B | |
+7.93% | 169B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Goldman Sachs Cuts Bristol-Myers Squibb's Price Target to $56 From $60